Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) (Haemonetics Corporation)
Welcome to the PulseAid listing for the Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) drug offered from Haemonetics Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Corporation |
| NON-PROPRIETARY NAME: | CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE |
| SUBSTANCE NAME: | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | EXTRACORPOREAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-01-10 |
| END MARKETING DATE: | 0000-00-00 |
Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) HUMAN PRESCRIPTION DRUG Details:
| Item Description | Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) from Haemonetics Corporation |
| LABELER NAME: | Haemonetics Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 32.7; 263; 22.2; 464(mg/mL; mg/mL; mg/mL; mg/mL) |
| START MARKETING DATE: | 2013-01-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57826-455_03cccd13-7d2f-4b47-9409-a888bb29bb12 |
| PRODUCT NDC: | 57826-455 |
| APPLICATION NUMBER: | BN000127 |
Other CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE Pharmaceutical Manufacturers / Labelers:
